Emyria (ASX:EMD) Interest Income : A$-0.06 Mil (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Emyria Interest Income?

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. Emyria's interest income for the six months ended in Dec. 2023 was A$0.04 Mil. Its interest income for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.06 Mil.

Emyria Interest Income Historical Data

The historical data trend for Emyria's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emyria Interest Income Chart

Emyria Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Interest Income

0.03

0.02

0.01

0.03

Emyria Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Income	Get a 7-Day Free Trial			0.09	-0.08	0.13	-0.10	0.04

Emyria Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

Interest Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.06 Mil.

Emyria (ASX:EMD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Emyria Ltd (ASX:EMD) » Definitions » Interest Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

D2 661 Newcastle Street, PO Box 1442, Leederville, WA, AUS, 6007

Website

https://www.emeraldclinics.com.au

Emyria Ltd operates a network of specialist medical clinics and uses purpose-built software and technology to gather clinical data from consenting patients. It operates in one segment of research and development.